Maso Capital Partners LTD Hutchmed (China) LTD Transaction History

Maso Capital Partners LTD

  • $84.2 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$25.8 - $34.61 $1.75 Million - $2.34 Million
-67,719 Closed
0 $0
Q1 2020

May 11, 2020
SELL
$15.19 - $29.51 $19,458 - $37,802
-1,281 Reduced 1.86%
67,719 $1.21 Million
Q3 2019

Nov 14, 2019
BUY
$17.84 - $22.69 $428,160 - $544,560
24,000 Added 53.33%
69,000 $1.23 Million
Q2 2019

Aug 13, 2019
BUY
$22.0 - $31.78 $990,000 - $1.43 Million
45,000 New
45,000 $990,000

Others Institutions Holding HCM

# of Institutions
65
Shares Held
6.88M
Call Options Held
6.2K
Put Options Held
1.1K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.5B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Maso Capital Partners LTD Portfolio

Follow Maso Capital Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maso Capital Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maso Capital Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email